Associate Director / Director, Clinical Development

<div class="content-intro"><p><strong><u>Company Overview</u></strong></p> <div class="x_elementToProof" data-olk-copy-source="MessageBody"> <div data-olk-copy-source="MessageBody">Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies. We are advancing an innovative portfolio of therapeutics, supported by a leadership team with deep experience in the design, development, and commercialization of cutting-edge therapies, including antibody-drug conjugates. Our pipeline includes varegacestat, an investigational gamma secretase inhibitor for which an NDA has been accepted by the U.S. FDA; IM-1021, a clinical-stage ROR1 ADC; IM-1617, a clinical-stage solid tumor ADC; and IM-3050, a clinical-stage FAP-targeted radioligand therapy. We are also advancing a broad portfolio of early-stage ADCs pursuing undisclosed solid tumor targets.</div> </div></div><p>&nbsp;</p> <p><span style="text-decoration: underline;"><strong><span data-contrast="auto">Position Overview</span></strong></span></p> <p><span data-contrast="auto">We are&nbsp;seeking&nbsp;a highly motivated physician to join Immunome as Associate Director&nbsp;/&nbsp;Director, Clinical Development, supporting the development of our investigational oncology pipeline. This individual will provide medical and scientific oversight for clinical studies and serve as a key member of the Clinical Development team, partnering closely with Clinical Operations, Biostatistics, Data Management, Regulatory Affairs, Pharmacovigilance, Medical Writing, and Translational&nbsp;Sciences.</span><span data-ccp-props="{}">&nbsp;</span></p> <p><span data-contrast="auto">The Associate Director/Director will&nbsp;be responsible for&nbsp;supporting protocol design and implementation, patient safety oversight, medical monitoring of ongoing trials, investigator and site engagement, medical review of emerging safety and efficacy data, and contribution to regulatory and scientific interactions. This position offers an opportunity to play a meaningful role in shaping the clinical development strategy for novel therapies addressing significant unmet needs in oncology.</span><span data-ccp-props="{}">&nbsp;</span></p> <p>&nbsp;</p> <p><span style="text-decoration: underline;"><strong><span data-contrast="auto">Responsibilities</span></strong></span></p> <ul> <li data-leveltext="" data-font="Symbol" data-listid="27" data-list-defn-props="{&quot;335552541&quot;:1,&quot;335559685